Guangdong Transtek Medical Electronics Co.Ltd(300562) raised funds annual deposit and use verification report xksbz [2022] No. zl10047
Guangdong Transtek Medical Electronics Co.Ltd(300562)
Verification report on annual deposit and use of raised funds
Page 1 of the table of contents 1. Assurance report on the annual storage and use of raised funds 1-2 2. Special report on the storage and actual use of raised funds 1-7 3. Comparison table of the use of raised funds 1-3
About Guangdong Transtek Medical Electronics Co.Ltd(300562)
Deposit and use of raised funds in 2021
Assurance report of special report
Xin Hui Shi Bao Zi [2022] No. zl10047 Guangdong Transtek Medical Electronics Co.Ltd(300562) all shareholders:
We are entrusted to carry out reasonable assurance on the attached special report on the deposit and use of raised funds of Guangdong Transtek Medical Electronics Co.Ltd(300562) (hereinafter referred to as ” Guangdong Transtek Medical Electronics Co.Ltd(300562) “) in 2021 (hereinafter referred to as “special report on raised funds”).
1、 Responsibilities of the board of directors
Guangdong Transtek Medical Electronics Co.Ltd(300562) the responsibility of the board of directors is to comply with the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) (CSRC announcement [2022] No. 15) of China Securities Regulatory Commission Prepare a special report on raised funds in accordance with the relevant provisions of the guidelines for self-regulation and supervision of listed companies on the Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem and the guidelines for self-regulation and supervision of listed companies on the gem of the Shenzhen Stock Exchange No. 2 – announcement format. This responsibility includes designing, implementing and maintaining the internal control related to the preparation of the special report on raised funds to ensure that the special report on raised funds is true, accurate and complete without false records, misleading statements or major omissions..
2、 Responsibilities of Certified Public Accountants
Our responsibility is to publish the assurance conclusion of the special report on raised funds on the basis of the implementation of the assurance work.
3、 Job overview
We have carried out the assurance business in accordance with the provisions of other assurance business standards for Chinese certified public accountants No. 3101 – assurance business other than audit or review of historical financial information. The standards require us to abide by the code of professional ethics, plan and implement the assurance work, so as to determine whether the special report on raised funds is in accordance with the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies (revised in 2022) (CSRC announcement [2022] No. 15) of China Securities Regulatory Commission in all major aspects The relevant provisions of the self regulatory guidelines for listed companies on the Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem and the self regulatory guidelines for listed companies on the gem of the Shenzhen Stock Exchange No. 2 – announcement format reflect truthfully the deposit and use of raised funds in Guangdong Transtek Medical Electronics Co.Ltd(300562) 2021 in all major aspects, so as to obtain reasonable assurance. In the process of carrying out the assurance work, we have implemented the procedures we consider necessary, including inquiry, inspection of accounting records and so on. We believe that our assurance work provides a reasonable basis for issuing assurance conclusions.
4、 Assurance conclusion
We believe that the special report on the deposit and use of raised funds in Guangdong Transtek Medical Electronics Co.Ltd(300562) 2021 is in accordance with the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) (CSRC announcement [2022] No. 15) of China Securities Regulatory Commission in all major aspects The relevant provisions of the self regulatory guidelines for listed companies on the Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem and the self regulatory guidelines for listed companies on the gem of the Shenzhen Stock Exchange No. 2 – announcement format truthfully reflect the deposit and use of raised funds in Guangdong Transtek Medical Electronics Co.Ltd(300562) 2021.
5、 Report usage restrictions
This report is only used by Guangdong Transtek Medical Electronics Co.Ltd(300562) for the purpose of disclosing the annual report of 2021, and shall not be used for any other purpose. Lixin Certified Public Accountants (special general partnership) Chinese certified public accountant: Liang Qianhai
Shanghai China
Chinese certified public accountant: Ma Yue
March 17, 2002
Guangdong Transtek Medical Electronics Co.Ltd(300562)
Special report on the deposit and use of raised funds in 2021
According to the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) (CSRC announcement [2022] No. 15) According to the relevant provisions of Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 2 – standardized operation of GEM listed companies and Shenzhen Stock Exchange self regulatory guidelines for GEM listed companies No. 2 – announcement format, the company makes the following special report on the deposit and use of raised funds in 2021:
1、 Basic information of raised funds (I) actual amount of raised funds and availability of funds
On October 26, 2016, with the approval of the reply on Approving the initial public offering of Guangdong Guangdong Transtek Medical Electronics Co.Ltd(300562) Electronics Co., Ltd. (zjxk [2016] No. 2432 document) issued by the China Securities Regulatory Commission, the company offered 14800000 ordinary shares with a par value of RMB 1.00 per share to the public on November 7, 2016, The issue price is 15.63 yuan per share, and the total amount of funds raised is 23132400000 yuan. After deducting the issuance expenses of 2206390000 yuan, the net amount of funds raised is 2092 Tangshan Port Group Co.Ltd(601000) 0 yuan.
On November 12, 2016, Lixin Certified Public Accountants (special general partnership) verified and confirmed the capital availability of the company’s initial public offering and issued the capital verification report (xksbz [2016] No. 712054).
On December 7, 2020, approved by the reply on approving Guangdong Guangdong Transtek Medical Electronics Co.Ltd(300562) Electronics Co., Ltd. to issue shares to specific objects for registration (zjxk [2020] No. 3233) issued by the China Securities Regulatory Commission, the company issued 23998780 shares to 14 specific investors (corresponding to 22 securities accounts) by issuing shares to specific objects, with an issue price of 16.48 yuan / share, The total amount of raised funds is 39549989440 yuan, and the issuance fee excluding tax is 1014382627 yuan. Haitong Securities Company Limited(600837) on February 10, 2021, the raised funds of 38679889672 yuan after deducting the underwriting recommendation fee of 870099768 yuan (including tax) will be transferred to the special storage account for raised funds designated by the company. The actual net amount of raised funds is 38679889672 yuan.
On February 22, 2021, Lixin Certified Public Accountants (special general partnership) verified the receipt of the above raised funds and issued the capital verification report of “Xin Kuai Shi Bao Zi [2021] No. zl10010”.
(II) amount used in previous years, amount used in current year and current balance
By the end of last year, the balance of the company’s special account for raised funds was 570425623 yuan.
In 2021, the company received a net amount of 38679889672 yuan of raised funds, and the interest and financial management received in the special account
The net amount of income after deducting bank charges is 801859198 yuan; The company actually used the raised funds of 5708918192 yuan, including 5669688954 yuan for the raised funds and 39229238 yuan for the permanent supplementary working capital in 2021; In 2021, the company used 9710329008 yuan of idle raised funds to temporarily supplement working capital. As of December 31, 2021, the balance of funds raised by the company was 24632927293 yuan (including the net amount of bank deposit interest received minus bank handling charges), including 14632927293 yuan in the special account for raising and 10000000000 yuan in the closed financial account.
2、 Deposit and management of raised funds (I) management of raised funds
In order to standardize the management of the company’s raised funds and improve the efficiency of the use of the raised funds, in accordance with the company law, the securities law, the measures for the administration of initial public offering and listing, the measures for the administration of the company’s securities issuance, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the company’s raised funds, the Shenzhen Stock Exchange GEM Listing Rules and other laws In accordance with the relevant provisions of laws and regulations and normative documents, and in combination with the actual situation of the company, the company has specially formulated the Guangdong Transtek Medical Electronics Co.Ltd(300562) raised funds management system (hereinafter referred to as the raised funds management system).
(II) tripartite supervision agreement of raised funds
According to the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the management system of raised funds and other requirements, the company implements a special account for the raised funds, and the company is divided into China Construction Bank Corporation(601939) Zhongshan branch, Bank Of China Limited(601988) Zhongshan Torch Development Zone Branch China Citic Bank Corporation Limited(601998) Zhongshan branch has set up a special account for raised funds, which is only used for the storage and use of the company’s raised funds and is not used for other purposes.
The company and the sponsor China Greatwall Securities Co.Ltd(002939) signed the tripartite supervision agreement on raised funds with Zhongshan Torch Development Zone Branch of Bank Of China Limited(601988) Co., Ltd. and China Citic Bank Corporation Limited(601998) Zhongshan branch on November 17, 2016, and signed the tripartite supervision agreement on raised funds with China Construction Bank Corporation(601939) Zhongshan branch on November 25, 2016.
On December 30, 2016, the company held the sixth meeting of the second board of directors to consider and approve the proposal on changing the implementation subject of some raised investment projects, and on March 2, 2017, the seventh meeting of the second board of directors considered and approved the proposal on the company’s use of the raised funds of the raised investment project “marketing network optimization construction project” to increase the capital of the wholly-owned subsidiary Shenzhen Guangdong Transtek Medical Electronics Co.Ltd(300562) Electronics Co., Ltd 。 On February 28, 2017, the company and its wholly-owned subsidiary, Shenzhen Guangdong Transtek Medical Electronics Co.Ltd(300562) Electronics Co., Ltd., signed the four party supervision agreement on raised funds with China Construction Bank Corporation(601939) Zhongshan branch and sponsor China Greatwall Securities Co.Ltd(002939) on February 28, 2017.
The company held the ninth meeting of the third board of directors on May 18, 2020 and 2020 on June 5, 2020
The second extraordinary general meeting of shareholders in passed relevant proposals on the company’s compliance with the conditions for non-public issuance of A-Shares on the gem. According to the authorization of the general meeting of shareholders, the board of directors of the company hired Haitong Securities Company Limited(600837) as the sponsor of the issue of shares to specific objects, and signed the corresponding sponsor agreement, The recommendation period is from the effective date of the agreement to the remaining time of the year when the shares are issued to specific objects for listing and the next two complete fiscal years. According to the measures for the administration of securities issuance and listing recommendation business and other relevant provisions of the CSRC, the company shall terminate the recommendation agreement with the original recommendation institution due to the company’s re application for issuing securities, and the additional recommendation institution shall complete the unfinished continuous supervision of the original recommendation institution. The original sponsor China Greatwall Securities Co.Ltd(002939) failed to complete the continuous supervision of the company’s initial public offering of shares, which shall be undertaken by Haitong Securities Company Limited(600837) .
In accordance with the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the management system of raised funds and other requirements, the company together with the sponsor Haitong Securities Company Limited(600837) separately cooperated with Bank Of China Limited(601988) Zhongshan Torch Development Zone sub branch China Citic Bank Corporation Limited(601998) Zhongshan branch re signed the tripartite supervision agreement on raised funds.
According to the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange and the management system of raised funds
